NCT04871789View on ClinicalTrials.gov

Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 20, 2021

Primary Completion Date

May 15, 2021

Study Completion Date

June 15, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Laboratory and instrumental examination

All patients will undergo a comprehensive examination to identify the consequences of COVID-19

Trial Locations (1)

129226

RECRUITING

Russian Clinical Research Center for Gerontology, Moscow

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
lead

Pirogov Russian National Research Medical University

OTHER

collaborator

Pfizer

INDUSTRY

NCT04871789 - Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19 | Biotech Hunter | Biotech Hunter